Arteris, Inc. (NASDAQ:AIP - Get Free Report) Director Raman Chitkara sold 5,000 shares of the stock in a transaction on Tuesday, April 14th. The stock was sold at an average price of $20.05, for a total value of $100,250.00. Following the completion of the transaction, the director directly owned 152,867 shares in the company, valued at $3,064,983.35. This trade represents a 3.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Arteris Stock Performance
Shares of AIP traded up $1.22 during trading hours on Thursday, hitting $21.52. The stock had a trading volume of 771,783 shares, compared to its average volume of 477,918. The firm has a market cap of $978.45 million, a P/E ratio of -26.24 and a beta of 1.43. The company's fifty day simple moving average is $16.26 and its 200 day simple moving average is $15.39. Arteris, Inc. has a 12-month low of $5.64 and a 12-month high of $21.57.
Arteris (NASDAQ:AIP - Get Free Report) last issued its earnings results on Thursday, February 12th. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.08) by $0.03. The firm had revenue of $20.14 million during the quarter, compared to analysts' expectations of $18.55 million. As a group, sell-side analysts predict that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Hedge funds have recently added to or reduced their stakes in the stock. Invesco Ltd. increased its position in shares of Arteris by 28.0% during the fourth quarter. Invesco Ltd. now owns 17,499 shares of the company's stock worth $271,000 after acquiring an additional 3,830 shares during the last quarter. Mercer Global Advisors Inc. ADV purchased a new stake in shares of Arteris during the fourth quarter worth about $162,000. VestGen Advisors LLC purchased a new stake in shares of Arteris during the fourth quarter worth about $218,000. Tudor Investment Corp ET AL purchased a new stake in shares of Arteris during the fourth quarter worth about $2,473,000. Finally, Numerai GP LLC purchased a new stake in shares of Arteris during the fourth quarter worth about $390,000. 64.36% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
AIP has been the topic of several research reports. Wall Street Zen raised Arteris from a "hold" rating to a "buy" rating in a research report on Saturday, March 21st. Northland Securities set a $24.00 price objective on Arteris in a research report on Friday, February 13th. Rosenblatt Securities reissued a "buy" rating and issued a $20.00 price objective on shares of Arteris in a research report on Friday, February 13th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Arteris in a research report on Wednesday, January 21st. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Arteris has a consensus rating of "Hold" and a consensus target price of $20.17.
Get Our Latest Stock Analysis on Arteris
Arteris Company Profile
(
Get Free Report)
Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.
Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.